As a result, many of these resources contain monomorphic SNPs that can yield a false positive rate higher than 20 %, or may not generate high data quality in an assay. Competing arrays were created in silico against putative SNPs often, which requires the extensive research community to invest time and money validating the genomic content themselves. By pre-screening all articles against stringent efficiency metrics, Affymetrix alleviates this burden for the researcher and guarantees each marker can be reliably genotyped for the uncommon allele in the Axiom assay. All variants were tested against a large, diverse sample set, including 1,300 samples across 11 populations from the International HapMap Task.The Africa Statement notes Kenya and Uganda are working to end FGM/C jointly, writing, ‘Uganda's Minister of Condition for Gender, Lukia Nakadama, said unless both countries worked together, the practice wouldn’t normally be wiped out’ . The Christian Science Monitor details initiatives to stop the practice in Uganda . This content was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an unbiased news service editorially, is a scheduled plan of the Kaiser Family members Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.